[ESMO 2026] Vaxcell-Bio Therapeutics: "CAR-MIL Shows 100% Survival in Animal Tests, Compared with J&J's Carvykti"
Predicted impact: Low
Preclinical animal trial data at a conference; early-stage and small.
Vaxcell-Bio Therapeutics박셀바이오
323990 · KOSDAQ · ₩323990 · 박셀바이오
₩3,790▼ ₩165 (4.17%)End-of-day · Oct 29, 2026 · End-of-day prices.
Theragen Bio Presents Poster on CAR-MIL Therapy for Multiple Myeloma at ESMO
Predicted impact: Low
Conference poster presentation on early-stage therapy research, a routine update.
Also known as: Vaxcell-Bio Therapeutics / 박셀바이오 / 323990 / KRX:323990
Source: KRX statistical information